Eric Topol

Topol warns that letting unapproved peptides be sold via compounding lists reduces incentives for clinical trials and leaves consumers vulnerable to aggressive sellers.

The chances of clinical trials getting done now are diminished. We will have more people who are prey to predators that will sell, sell, sell.

Topol argues that peptide promoters claiming success should reinvest profits into rigorous clinical research.

If influencers and companies really believe these peptides are helping people, then they should put their profits back into rigorous research.

Topol argues medicine must shift from reactive treatment of sickness to prevention, and believes it will.

the fact that we are only treating, treating, treating, trying to deal with sick, sick sickness instead of preventing, preventing, preventing that's the shift that has to take place. And I believe it will in the future.

Topol says smartwatch atrial fibrillation detection is now about 99% sensitive and specific, a major medical advance.

the ability to diagnose atrial fibrillation now through your wristband watch it's so accurate now. It's like 99% sensitive 99% specific. it's really been extraordinary picking up what is a very serious arrhythmia for its stroke risk

Topol warns that shrinking clinic visit times to 12 minutes has eroded the patient-doctor relationship.

the time with a patient for a clinic appointment was being dropped steadily from a new patient, like, have an hour to having 12 minutes. Right. And, you know, to be able to get the entire history of a person and to respond to their concerns and what needs to be done in 12 minutes of somebody you've never seen before. It's ridiculous.

Topol says AI tools empower patients and free up clinician time, helping rebuild the patient-doctor relationship.

So that's decompressed the need for doctors as well and given patients more charge. So together, this gift of time, we're on the march to restore time and rebuild the patient doctor relationship.

Topol predicts AI will become as routine in medicine as tumor genomics is in oncology today.

if you're an oncologist now, we don't talk about that anymore because it's part of the care of patients that you're going to get genomics of the tumor to figure out what is the best treatment. That's what's going to happen with AI eventually, just a matter of when

Topol criticizes longevity pseudoscience and argues the focus should be on extending healthspan rather than lifespan.

there were lots of pseudoscience and influencers out there peddling longevity and making lots of mistakes, So I said, I got to get this thing straight. There's so much confusion. There's also this misplaced emphasis on longevity when what we really want to do is keep people healthier, longer

Topol says cardiovascular disease, cancer and neurodegeneration are highly preventable given a roughly 20-year runway, which AI and multi-layer data can help target.

these three big age related diseases cardiovascular, cancer, neurodegenerative are eminently preventable. I had no idea. that we're talking about a 20 year runway for these three diseases.

Topol says new medical graduates are lucky to enter an AI era that will empower prevention and restore patient relationships.

I wish I were them. I mean, they are so darn lucky We talked about the information era for decades, but they're really going to hit it